A phase 1/1b Study of the Theranostic Pair RYZ811 (diagnostic) And RYZ801 (therapeutic) In Patients With Glypican-3-positive (gpc3+) Previously Treated, Unresectable Hepatocellular Carcinoma

rayzebio_logo_grt_gry
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Click here to read more about our use of cookies.